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ABSTRACT
Objectives: Study the time development of
methicillin-resistant Staphylococcus aureus (MRSA)
and forecast future behaviour. The major question: Is
the number of MRSA isolates in Norway increasing and
will it continue to increase?
Design: Time trend analysis using non-stationary
γ-Poisson distributions.
Setting: Two data sets were analysed. The first data
set (data set I) consists of all MRSA isolates
collected in Oslo County from 1997 to 2010; the
study area includes the Norwegian capital of Oslo and
nearby surrounding areas, covering approximately
11% of the Norwegian population. The second data
set (data set II) consists of all MRSA isolates
collected in Health Region East from 2002 to 2011.
Health Region East consists of Oslo County and four
neighbouring counties, and is the most populated
area of Norway.
Participants: Both data sets I and II consist of all
persons in the area and time period described in the
Settings, from whom MRSA have been isolated.
Primary and secondary outcome measures:
MRSA infections have been mandatory notifiable in
Norway since 1995, and MRSA colonisation since
2004. In the time period studied, all bacterial samples
in Norway have been sent to a medical
microbiological laboratory at the regional hospital for
testing. In collaboration with the regional hospitals in
five counties, we have collected all MRSA findings in
the South-Eastern part of Norway over long time
periods.
Results: On an average, a linear or exponential
increase in MRSA numbers was observed in the data
sets. A Poisson process with increasing intensity did
not capture the dispersion of the time series, but a γ-
Poisson process showed good agreement and captured
the overdispersion. The numerical model showed
numerical internal consistency.
Conclusions: In the present study, we find that the
number of MRSA isolates is increasing in the most
populated area of Norway during the time period
studied. We also forecast a continuous increase until
the year 2017.
INTRODUCTION
The bacterium Staphylococcus aureus (S. aureus)
is part of the human ﬂora, colonising about a
third of the world’s population.1 S. aureus has
the ability to quickly develop resistance to
antimicrobial agents.2 When acquiring the
resistance gene mecA, the bacterium is called
methicillin-resistant Staphylococcus aureus
(MRSA), and the acquisition results in resist-
ance to all β-lactam antibiotics. MRSA is
Strengths and limitations of this study
▪ The strength of this study is the advanced time
series development used.
▪ The limitations of this study: The data were col-
lected from five different hospitals. However, a
difference in the way data was retrieved is
unlikely as the data extraction was quite straight-
forward. Temporarily increased detection and
screening may result in more methicillin-resistant
Staphylococcus aureus (MRSA) being identified
over shorter periods of time, thereby creating
bias in our estimates of MRSA over time. Our
model is based on a Poisson or γ-Poisson distri-
bution, with exponential/linear/power time func-
tions that are estimated by the least square fit
method. The maximum likelihood principle may
have been applied instead of the least square
method used here. To account for the strong
bursting behaviour in MRSA, we may consider,
as other alternatives, different time estimators of
λ(t). One possibility, for instance, is to include
deterministic low frequency components. Yet
another possibility is to apply different stochastic
processes, for instance, generated by stochastic
differential equations. However, a more realistic
model is difficult to construct unless we know
more about the biological or administrative
reasons for the bursting behaviour. Lastly our
forecast depends on the choice of a linear or
exponential model or power for the time trend.
However, all functions show an increasing trend.
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globally spread and contributes signiﬁcantly to medical
treatment failures and deaths.3 MRSA is one of the
antibiotic-resistant bacteria having the most impact on
human health, being responsible for over 80 000 severe
infections and over 11 000 deaths per year in the USA
alone, and accounting for more than one-half of the
nosocomial S. aureus strains in most Asian countries.4
In Norway, MRSA infections became mandatory notiﬁ-
able in 1995 and its incidence has been monitored
closely ever since. Today, the incidence is still rather rare
with 0.029% of the population being infected in 2013
(http://www.msis.no, http://www.ssb.no). Despite the
low incidence, both ofﬁcial numbers from the Norwegian
National Institute of Public Health (NIPH) and several
studies reveal an increasing incidence of MRSA in
Norway during the past two decades (http://www.msis.
no).5–9 Our group recently published a study on the pro-
portion of methicillin-resistance in S. aureus isolates
regardless of infection type in the most populated area of
Norway over a 13 year long time period.9 The analyses
revealed a non-linear increase in the proportion of
MRSA in the time period 1997 to 2010, while the propor-
tion of S. aureus (MRSA and methicillin-sensitive S. aureus
(MSSA)) remained relatively stable. The largest increase
of MRSA is found in the community setting which could
indicate an increased import of MRSA from abroad or
MRSA becoming endemic in Norway. The Norwegian
MRSA infection control guidelines were introduced and
updated in 2004 and 2009, respectively.10 11 The guide-
lines follow a ‘search and destroy’ policy with a primary
focus on the hospital settings. The main changes in the
updated vision of the guidelines were broader and more
detailed guidelines for the handling of MRSA-infected
persons in healthcare services outside hospitals. The
introduction of the guidelines did not have a signiﬁcant
effect on the increase of methicillin-resistance in S. aureus
when implemented in our last study.9
Several studies have performed time series analysis to
study both the evolution of antimicrobial resistance and
infection control policies,12–16 to study MRSA colonisa-
tion and infection17 18 and to study the temporal associ-
ation between different variables and the incidence of
MRSA infections.19 A time series analysis does not neces-
sarily assume that the data are generated independently;
the dispersion may vary with time and the time series
may be governed by a trend that could have cyclical
components. To check model adequacy, the use of dis-
persion and deviance is often used.16
In the present article, we use stochastic theory to
model the occurrence of MRSA infections in Norway.
We apply a non-stationary Poisson process for MRSA
infections and compare it with time series of the data.
To account for overdispersion in the data we applied the
γ-Poisson distribution. The analyses in the present study
apply MRSA counts and not, as in our recent study,9 the
proportion of MRSA. This has some advantages, but also
some disadvantages. The advantage is that the propor-
tion is difﬁcult to collect correctly; MRSA count is more
trustworthy. We have collected all MRSA ﬁndings in the
South-Eastern part of the country over long time
periods. This makes the MRSA count in the time period
studied reliable. MSSA is not mandatory notiﬁable in
Norway, making it even more difﬁcult to extract the
MRSA proportion. However, the disadvantage is that the
count of MRSA may be biased due to a varying number
of tests for MRSA. It is notable that in stochastic theories
it is essential how randomness is accounted for.20
Different models of the same phenomena may give
different results. We apply non-stationary γ-Poisson distri-
butions for the count of MRSA isolates in a Health
Region in Norway, including exponential and linear
functions to describe the temporal trends in the
S. aureus isolates resistant to methicillin. We use the
ﬁtted models to make 5-year predictions on the future
development of MRSA in the region over time.
Data
The data used in this paper, study area, sampling
methods, inclusion parameters have been partly pre-
sented previously.9 We have extended the study period
by 3 years for data set II. To summarise: Two data sets
were analysed. The ﬁrst data set (data set I) consists of
all MRSA isolates collected in Oslo County from 1997 to
2010; the study area includes the Norwegian capital of
Oslo and nearby surrounding areas, covering approxi-
mately 11% of the Norwegian population. The second
data set (data set II) consists of all MRSA isolates
collected in Health Region East from 2002 to 2011.
Health Region East consists of Oslo County and four
neighbouring counties and is the most populated area
of Norway; it includes many large and small cities and
rural areas, and covers approximately 36% of the
Norwegian population. MRSA isolates from Oslo County
are included in both data sets, but due to the use of two
different databases for extraction of data, SWISSLAB
(Swisslab, GmbH, Berlin, Germany) for data set I and
MICLIS (Miclis AS, Lillehammer, Norway) for data set
II, and due to other factors outlined and discussed in
our previous paper,9 the two data sets for Oslo county
could not be combined.
A model for the number of MRSA
Let t be the continuous time variable. We model the
monthly reported number of MRSA isolates as a random
variable Xti , where ti; i ¼ 1; . . ., is an index variable for each
month during the study period. Mostly we measure time
from a speciﬁc time point. Thus, we let ti ¼ 1; 2 . . . tmax. In
ﬁgures where year is used we let the year be deﬁned by
Year ¼ Year0 þ ðt0  1þ tiÞ=12; ti ¼ 1; 2    tmax, where t0
is the number of the month in the year when the study
starts. Year0 is the year the study starts. For simplicity, we
write i instead of ti in the formulas.
The strategy for constructing a feasible stochastic process
should be based on a three-step iterative cycle. The ﬁrst is
model identiﬁcation, the second is model estimation and
ﬁnally, the diagnostic checks on model adequacy.
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Model identification
The Poisson process is a natural starting point for count
data analysis. The non-stationary Poisson process is the
next step when modelling non-stationary processes,
though it is often inadequate due to overdispersion.21
Overdispersion may be due to unobserved hetero-
geneity, may arise because the process of generating the
ﬁrst events may differ from that determining later events
(hurdle model or non-stationary model), or may arise
due to the failure of the assumption of independence of
events. The probability pXi of observing Xi ¼ x is
assumed to be a non-stationary Poisson distribution
according to:
pXi(Xi ¼ x) ¼
mod l
x
x!
Exp(lðtÞ) ð1Þ
where ‘mod’ refers to the model assumption. We note
that l is assumed to depend on time. The expectation
(mean) and variance is found to be:
m ¼ E(Xi) ¼ l;s2 ¼ Var(Xi) ¼ l ð2Þ
We let m and s2 denote the expectation and the
variance.
In principle, by studying an inﬁnite number of realisa-
tions of Xi, l ¼ lðtÞ is simply given by l ¼ E(Xi).
However, we have only one non-stationary time series Xi
available for use and in addition, only a ﬁnite number of
time points. Consequently, we construct an estimator
l^ ðtÞ for lðtÞ that is as simple as possible, but which still
gives a good representation of the available data.
However, there is no unique method for the construc-
tion of such an estimator and as a ﬁrst hypothesis, l^ ðtÞ
is set to be deterministic. We apply a least square ﬁt
(LSF) and compare different functional representations
for the time trend of l^ ðtÞ: an exponential function and
a linear function. Linear regression is commonly used,
but may not be the most appropriate for count data,
which are non-negative integers. Essentially exponential
growth occurs in two different ways: If an entity is self-
reproducing, then exponential growth is inherent. If an
entity is driven by something else that is growing expo-
nentially, then its’ growth is derived.
Model estimation
In this model estimation section, we establish the para-
meters of the stochastic model that is used for forecast.
The realisation of the stochastic process in equation (3)
is used to compare with the given data and for forecast.
We apply a LSF of the data of ~xi of MRSA to ﬁnd the
estimator l^ ðtÞ of the expectation. We construct the rea-
lisations based on the estimator l^ ðtÞ:
Xi ¼ Random ½PoissonDistribution½l^ ðiÞ ð3Þ
Equation (3) gives the simulated number of MRSA for
each month where we numerically draw a random
number from a Poisson distribution with intensity par-
ameter l^ ðiÞ that varies with time.
Diagnostic checks on model adequacy and overdispersion
As the ﬁrst check on the least square ﬁt estimator, we
simulate one time series by considering l^ ðtÞ as input.
We calculate xsimi and apply the LSF to ﬁnd l^
sim, which
is compared with l^ ðtÞ. Further to test model adequacy
and dispersion we calculate
DiffSimðiÞ ¼(~xsimi  l^
simðiÞ)2;
~Var
Sim ¼LSF(DiffSim); V^arSim ¼ l^ sim
DiffExpðiÞ ¼(~xi  l^ ðiÞ)2;
~Var
Exp ¼LSF(DiffExp); V^arExp ¼ l^
ð4Þ
Here ~xiis the measured number of MRSA counts, and
~xsimi is the simulated number of MRSA counts.
LSF(DiffExp) is the LSF to the squared difference
between the MRSA data and the estimated intensity
based on the MRSA data. LSF(DiffSim) is the LSF to the
squared difference between the simulated data and the
estimated intensity based on the simulated data.
Good model adequacy gives l^ sim  l^ ,
~Var
Sim  V^arSim  V^arExp. However, overdispersion in
the data gives ~Var
Exp
. V^ar
Exp
which we account for by
adopting a γ-Poisson distribution (also called negative
binomial model), which is a common choice for captur-
ing overdispersion in the Poisson distribution.22 This
means that we let the l in the Poisson distribution be
stochastic according to the γ distribution. The overdis-
persion in our data may be due to failure of the assump-
tion of independence or correlation of events. Indeed,
particular assumptions of observed heterogeneity due to
dependence and correlation lead to the γ-Poisson distri-
bution.23 In general, we believe that the overdispersion
is due to individuals acting as a group (ie, epidemic out-
breaks). However, individual responses to covariates,
such as dates, may also be an explanation.
The γ distribution has two parameters called a and b
(see online supplementary appendix A). It can be
shown that (see for instance online supplementary
appendix A) equation (2) becomes
m ¼ b
a
;s2 ¼ b
a
1þ a
a
ð5Þ
Here b (often denoted by r) is the scale factor and 1=a
(often denoted by u) is the shape factor. When a and b
approach inﬁnity, the overdispersion approaches zero.
To construct an estimator for a and b, we apply
l^ ¼ b^
a^
; ~Var
Exp ¼ b^
a^
1þ a^
a^
¼ l^ 1þ a^
a^
) a^ ¼ l^
~Var
Exp  l^
; b^ ¼ l^ a^ ¼ l^
2
~Var
Exp  l^
ð6Þ
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Thus, altogether we use two different LSFs to ﬁnd a^ ; b^ .
One for l^ based on the LSF to ~xi, and one for ~Var
Exp
based on the LSF to (~xi  l^ ðiÞ)2. As a ﬁnal test of the
algorithm, we generate data by applying the γ-Poisson
distribution with parameters a^ ; b^ . From these data we
calculate the dispersion for comparison with ~Var
Exp
.
The simulations were performed in Mathematica 8
(Wolfram Research Inc, Champaign, Illinois, USA).
Ethics statement
The approval, from both the Norwegian Regional
Committees for Medical and Health Research Ethics,
South East, and the representative of privacy protection
at Akershus University Hospital Trust, includes the
acceptance of using microbiological data from the
routine databases in the microbiological laboratories
without the need for written consent. Written consent
was not needed in the present study as the material used
is of microbial origin only and no personally identiﬁable
information was gathered. The information gathered
from microbial data cannot be traced back to the person
from whom it was collected.
NUMERICAL AND EXPERIMENTAL RESULTS
Data set I: Oslo County, 1997–2010
Trends in identified MRSA
Figure 1 shows the number of cases of MRSA. The trend
is increasing. The exponential function was found to
give the best ﬁt for data set I, and this was closely
followed by the linear and power functions. In all cases,
the choice of a linear or exponential model or power
function for the time trend produced only marginally
different model ﬁts.
The mean monthly number of MRSA cases in Oslo
County was estimated to increase by a factor of 5.4 in
the study period, from 2.7 cases (SD 1.0–4.1) in 1997 to
14.5 cases (SD 11.0–18.8) at the end of 2010, thereby
representing monthly incidence rates of 0.5 and 2.4 per
100 000 inhabitants in 1997 and 2010, respectively
(population statistics from http://www.ssb.no).9
A visual inspection of ﬁgure 1 suggests that the scatter
(dispersion) in the data is larger than in the simulation
based on the Poisson distribution. Figures 1 and 2 show
that l^ sim  l; ~VarExp . ~VarSim  V^arSim  V^arExp.
The dispersion of the data is signiﬁcantly larger than
the dispersion in the Poisson model. To account for
overdispersion we use the γ-Poisson distribution. The
scatter (dispersion) of γ-Poisson distribution is much
more in agreement with the data (ﬁgure 1).
Figure 3 shows the γ-distribution for data set I for
1998, 2006 and 2010. We observe that the γ-distribution
becomes broader with time and that the expectation
shifts to higher p values.
Data set II: Health Region East, 2002–2011
Trends in identified MRSA cases
In the study period from January 2002 to December 2011
(120 months), a linear time trend was found to provide
Figure 1 The monthly number of methicillin-resistant Staphylococcus aureus cases in Oslo County: September 1997 to 2010.
Thick black curve: l^ ðtÞ based on exponential LSF of data. Thin black curve: l^ ðtÞbased on linear LSF of data. Red dashed curve:
95% confidence bounds for exponential and linear LSF of the data. Blue curve: l^ simðtÞ based on exponential LSF of simulated
data. ▪: Data, □: Stochastic simulation based on the Poisson distribution.⋆: Stochastic simulation based on the γ-Poisson
distribution.
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the best description of the mean monthly number of
MRSA cases in Health Region East, and was marginally
better compared to the power function ﬁt and the expo-
nential ﬁt. However, as for data set I, the choice of a
linear, exponential model or power for the time trend
produced only marginally different model ﬁts.
A visual inspection of ﬁgure 4 suggests that the scatter
(dispersion) in the data is larger than in the simulation
Figure 2 The SD of methicillin-resistant Staphylococcus aureus cases in Oslo County: September 1997 to 2010. Blue curve:
ﬃﬃﬃﬃﬃﬃﬃﬃ
~Var
p Sim
; Green curve:
ﬃﬃﬃﬃﬃﬃﬃﬃ
V^ar
p Exp
; Red curve:
ﬃﬃﬃﬃﬃﬃﬃﬃ
V^ar
p Sim
; Black curve:
ﬃﬃﬃﬃﬃﬃﬃﬃ
~Var
p Exp
Black dashed curve: Variance calculated from
simulated data by using the γ-Poisson distribution.
Figure 3 The γ-distribution at different times in data set I. Green curve: the γ-distribution in 1998 for data set I; Blue curve: the
γ-distribution in 2005 for data set I; Red curve: the γ-distribution in 2010 for data set I.
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based on the Poisson distribution. Figures 4 and 5 show,
as for data set I, the dispersion of the data is signiﬁcantly
larger than the dispersion in the Poisson model. To
account for overdispersion, we use the γ-Poisson
distribution.
Figure 6 shows the γ distribution for data set II for
2002, 2005 and 2010. We observe that the γ distribution
becomes broader with time and that the expectation
shifts to higher p values. In general, the trends for data
set I and data set II are much the same.
Forecasting
We use the model to forecast future development. Both
linear and exponential extrapolation is used in our
forecast. The different CIs are also highlighted in
ﬁgure 4.
CONCLUSION
In the present study, we ﬁnd that the number of MRSA
isolates is increasing in the most populated areas of
Norway during the time period studied. We also forecast
a continuous increase until the year 2017. MRSA infec-
tions have been mandatory notiﬁable in Norway since
1995 and MRSA colonisation, since 2004. In the time
period studied, all bacterial samples in Norway, with few
exceptions, have been sent to a medical microbiological
laboratory at the regional hospital for testing. In collab-
oration with the regional hospitals in ﬁve counties, we
have collected all MRSA ﬁndings in the South-Eastern
part of the country over long time periods. This makes
the MRSA count in the time period studied reliable.
MSSA is not mandatory notiﬁable making it more difﬁ-
cult to extract the MRSA proportion. We believe that the
results from the present study both compliments and
strengthen our previous work.9 The results from both
studies show an increase in methicillin-resistance in
S. aureus and the increase is larger than the ofﬁcial
numbers from the Norwegian NIPH.
The causes of the increased level of methicillin-
resistance found in our study area are not known, but de
novo evolution from MSSA to MRSA, local establishment
of MRSA or increased import from abroad could be
important reasons. According to the NIPH, both domes-
tic and import cases are increasing (http://www.msis.
no). An increase in domestic cases can indicate that the
bacteria have become endemic.24 Import has been seen
as a major contribution to the MRSA increase in our
neighbouring country, Sweden.25 26 Population mobility
is seen as a main factor in globalisation of public health
threats and risks, and especially in the spread of anti-
microbial resistance.27 There is a vast number of persons
moving large geographical distances each year for
various reasons: vacation travels, medical tourists, refu-
gees, work travels, asylum seekers, military conﬂicts and
natural disasters. Our study area is the most densely
populated area in Norway and also includes the largest
airport in the country. It is also the area settling the
most number of refugees and asylum seekers (http://
www.imdi.no). The relatively large number of people
Figure 4 The monthly number of methicillin-resistant Staphylococcus aureus cases in Health Region East: 2002 to 2011.
Extrapolation to 2017. Thick black curve: l^ ðtÞ based on exponential LSF of data. Thin black curve: l^ ðtÞbased on linear LSF of
data. Red dashed curve: 95% confidence bounds on exponential and linear LSF of data. ▪: Data, □: Stochastic simulation based
on the Poisson distribution. ⋆: Stochastic simulation based on the γ-Poisson distribution. Extrapolation to 2017.
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travelling to and through the study area makes it prob-
able and likely that MRSA is imported into the area.
Previous studies from our group have revealed hetero-
geneity in the genetic lineages of the study area, sup-
porting the theory of MRSA import.6 8
Bursting behaviour (dispersion) in the MRSA cases
appeared more irregular throughout the time periods
than expected from the Poisson stochastic model alone
(ﬁgures 1 and 4). In Oslo County, several larger and
smaller endemic-like outbreaks of MRSA have been
Figure 6 The γ-distribution at different times in data set II. Green curve: the γ-distribution in 2002 for data set II; Blue curve: the
γ-distribution in 2005 for data set II; Red curve: the γ-distribution in 2010 for data set II.
Figure 5 The SD of methicillin-resistant Staphylococcus aureus cases in Health Region East: 2002 to 2011. Blue curve:
ﬃﬃﬃﬃﬃﬃﬃﬃ
~Var
p Sim
; Green curve:
ﬃﬃﬃﬃﬃﬃﬃﬃ
V^ar
p Exp
; Red curve:
ﬃﬃﬃﬃﬃﬃﬃﬃ
V^ar
p Sim
; Black curve:
ﬃﬃﬃﬃﬃﬃﬃﬃ
~Var
p Exp
; Black dashed curve: Variance calculated from
simulated data by using the γ-Poisson distribution.
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documented during the study period.8 28 29 The strong
bursting behaviour may be related to situations in which
an MRSA carrier or infected person has been discovered
at a healthcare institution. By applying a γ-Poisson distri-
bution that accounts for overdispersion, we account for
the dispersion (ﬁgures 2 and 4).
The major limitations in our study are:
The data were collected from ﬁve different hospitals.
However, a difference in the way data was retrieved is
unlikely as the data extraction was quite straightfor-
ward. The number of MRSA counts may depend on
the population size if the intensity of the Poisson
process increases with the population size. However,
we have seen no sign of such a relationship. False
negative probability is negligible since the sensitivity of
both culture and molecular detection methods are
very good.30 We believe that not testing for MRSA is by
far a much larger problem.
Temporarily increased detection and screening may
result in more MRSA being identiﬁed over shorter
periods of time, thereby creating bias in our estimates
of MRSA over time. Our model is based on a Poisson
or γ-Poisson distribution, with exponential and linear
time functions that are estimated by the least square
ﬁt method. The maximum likelihood principle may
have been applied instead of the least square method
used here. A diagnostic plot of the empirical ﬁt of the
variance using LSF on squared residuals suggested
that the overdispersion in the data was signiﬁcant.
Other diagnostic ﬁts may more directly underscore
the maximum likelihood principle. To account for the
strong bursting behaviour in MRSA, we may, as other
alternatives, consider different time estimators for lðtÞ.
One possibility is, for instance, to include determinis-
tic low frequency components. Yet another possibility
is to apply different stochastic processes, for instance,
generated by stochastic differential equations.18
However, a more realistic model is difﬁcult to con-
struct unless we know more about the biological or
administrative reasons for the bursting behaviour.
Interhospital variability may be modelled in future
research where different random effects may be
accounted for separately. This will increase insight on
how demographics inﬂuence MRSA development.
Lastly, our forecast depends on the choice of a linear or
exponential model for the time trend. However, all
functions show an increasing trend.
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